Conclusion: LINC01503 is highly expressed in HCC and promotes the progression of HCC via MAPK/ERK pathway, which maybe a new potential biomarker and therapeutic target for HCC. The gene discussed is LINC01503; the disease is hepatocellular carcinoma.